Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.140
+0.010 (0.88%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Boundless Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -58.2 | -65.36 | -49.43 | -45.9 | -25.21 |
| Depreciation & Amortization | 1.25 | 1.09 | 0.96 | 0.94 | 0.68 |
| Loss (Gain) From Sale of Investments | -2.59 | -5.06 | -3.3 | 0.5 | 0.54 |
| Stock-Based Compensation | 6.13 | 7.52 | 3.34 | 2.29 | 1.16 |
| Other Operating Activities | 3.29 | 2.65 | 2.39 | 1.7 | 0.42 |
| Change in Accounts Payable | 1.63 | 0.78 | 1.66 | 1.91 | 1.22 |
| Change in Other Net Operating Assets | 1.83 | -2.45 | -2.46 | -1.05 | -2.06 |
| Operating Cash Flow | -46.66 | -60.84 | -46.86 | -39.6 | -23.25 |
| Capital Expenditures | -0.55 | -2.54 | -0.63 | -1.07 | -2.03 |
| Investment in Securities | 38.35 | -23.57 | -37.63 | 17.2 | -57.25 |
| Investing Cash Flow | 37.8 | -26.1 | -38.26 | 16.13 | -59.29 |
| Issuance of Common Stock | 0.14 | 93.17 | 0.18 | 0.13 | 0.21 |
| Other Financing Activities | - | -3.35 | -1.96 | - | - |
| Financing Cash Flow | 0.14 | 89.82 | 97.9 | 0.13 | 105.53 |
| Net Cash Flow | -8.72 | 2.88 | 12.78 | -23.34 | 22.99 |
| Free Cash Flow | -47.21 | -63.38 | -47.49 | -40.66 | -25.28 |
| Free Cash Flow Per Share | -2.11 | -3.73 | -39.05 | -37.04 | -29.38 |
| Levered Free Cash Flow | -37.53 | -37.58 | -30.95 | -24.76 | - |
| Unlevered Free Cash Flow | -37.53 | -37.58 | -30.95 | -24.76 | - |
| Change in Working Capital | 3.46 | -1.68 | -0.8 | 0.87 | -0.84 |
Source: S&P Capital IQ. Standard template.
Financial Sources.